Document is current
Any future updates will be listed below
-
Authors
Li, Haichang
Lin, Pei-Hui
Gupta, Pranav
Li, Xiangguang
Zhao, Serena Li
Zhou, Xinyu
Li, Zhongguang
Wei, Shengcai
Xu, Li
Han, Renzhi
Lu, Jing
Tan, Tao
Yang, Dong-Hua
Chen, Zhe-Sheng
Pawlik, Timothy M.
Merritt, Robert E.
Ma, Jianjie https://orcid.org/0000-0003-3865-6112
- License Information
-
More Information
Article History
Received: 25 March 2021
Accepted: 28 August 2021
First Online: 14 September 2021
Declarations
:
: All animal care and usage was done in accordance with federal policies and guidelines and approved by The Ohio State University’s IACUC.
: Not applicable
: JM and TT have equity interest in TRIM-edicine, which develops MG53 for the treatment of human disease. Patents on the use of MG53 are held by Rutgers University-Robert Wood Johnson Medical School and The Ohio State University.
